Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
The initiation and prevention of multiple sclerosis.
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Patient perceptions of multiple sclerosis and its treatment.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Immunopathology of multiple sclerosis.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Pages
« first
‹ previous
…
128
129
130
131
132
133
134
135
136
…
next ›
last »